| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.09 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.068 | 0.2 |